Ravi Srinivasan
Principal investigator, leads Onconano Medicine, Inc..
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$1.8MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 1, 2020 | NIH | SBIR Phase II Novel Fluorescent Diagnostic Agents for Detection, Staging, andIntraoperative Imaging of Tumors | $790 | Onconano Medicine, Inc. |
| Sep 6, 2019 | NIH | SBIR Phase II Novel Fluorescent Diagnostic Agents for Detection, Staging, andIntraoperative Imaging of Tumors | $837K | Onconano Medicine, Inc. |
| Aug 22, 2019 | NIH | SBIR Phase II Novel Fluorescent Diagnostic Agents for Detection, Staging, andIntraoperative Imaging of Tumors | $4K | Onconano Medicine, Inc. |
| Sep 17, 2018 | NIH | SBIR Phase II Novel Fluorescent Diagnostic Agents for Detection, Staging, andIntraoperative Imaging of Tumors | $710K | Onconano Medicine, Inc. |
| Sep 21, 2017 | NIH | SBIR Phase II Novel Fluorescent Diagnostic Agents for Detection, Staging, andIntraoperative Imaging of Tumors | $269K | Onconano Medicine, Inc. |
Peer ranks
Federal funding#1,316
Awards as PI#470
Patents#505
Companies
- Onconano Medicine, Inc.Leads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.